| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 10/27/2005 | CA2562343A1 Hepatotoxicity molecular models |
| 10/27/2005 | CA2562304A1 Method of examining malignant tumor |
| 10/27/2005 | CA2561877A1 Use of mic-1 or modulating agent thereof to modulate appetite or body weight |
| 10/27/2005 | CA2561830A1 Monoclonal antibodies with specificity for fetal erythroid cells |
| 10/27/2005 | CA2561742A1 Methods for identifying risk of osteoarthritis and treatments thereof |
| 10/27/2005 | CA2561545A1 Human glycoprotein hormone superagonists and uses thereof |
| 10/27/2005 | CA2561494A1 Diagnosis and treatment of myeloid and lymphoid cell cancers |
| 10/27/2005 | CA2559870A1 Mass spectrometry of antibody conjugates |
| 10/27/2005 | CA2554209A1 Cell display libraries |
| 10/27/2005 | CA2553684A1 Biosensor based on directed assembly of particles |
| 10/26/2005 | EP1589438A2 Method and device for monitoring concentration of an analyte in a living human or animal body |
| 10/26/2005 | EP1589342A2 Use of radioligands to screen inhibitors of amyloid-beta peptide production |
| 10/26/2005 | EP1589341A2 Method of selective peptide isolation for the identification and quantitative analysis of proteins in complex mixtures |
| 10/26/2005 | EP1589340A1 Reactive chip and method for detecting bond of target substance using that chip |
| 10/26/2005 | EP1589339A2 Methods for quantitatively determining lengthwise shrinkage in wood products |
| 10/26/2005 | EP1589338A2 Method of reducing the damage on heating installations and liquid, low-sulphur fuel |
| 10/26/2005 | EP1589334A1 Body fluid component analyzing system |
| 10/26/2005 | EP1589117A2 Methods for determining the relationship between hybridization signal of probes and target DNA copy number |
| 10/26/2005 | EP1589109A2 VMP-like sequences of pathogenic borrelia |
| 10/26/2005 | EP1589103A1 Method of screening agent for improving memory and learning ability |
| 10/26/2005 | EP1589101A1 Novel protein and its gene |
| 10/26/2005 | EP1589100A1 Transcriptional activator |
| 10/26/2005 | EP1589099A1 Immortalized natural killer cell line |
| 10/26/2005 | EP1589097A1 Isolation and culture of a high purity population of cone photoreceptor cells, and biological applications thereof |
| 10/26/2005 | EP1589029A2 Pyrazinone protease inhibitors |
| 10/26/2005 | EP1589028A2 Modified oligonucleotides, their preparation and their use |
| 10/26/2005 | EP1589025A2 Nucleic acid labeling compounds |
| 10/26/2005 | EP1588755A1 Target detecting device and target capturer, molecule adsorption/desorption device and molecule adsoprtion/desoption method, and protein detecting device and protein detecting method |
| 10/26/2005 | EP1588713A1 Production of human papillomavirus HBV-11 capsid protein L1 and virus-like particles |
| 10/26/2005 | EP1588712A1 Modulators of regulatory proteins |
| 10/26/2005 | EP1588355A2 Optical disc system and related methods for analysis of microscopic structures |
| 10/26/2005 | EP1588181A2 Method of diagnosing colorectal adenomas and cancer using proton magnetic resonance spectroscopy |
| 10/26/2005 | EP1588173A2 Affinity fishing for ligands and proteins receptors |
| 10/26/2005 | EP1588171A2 Improved beta-arrestin based screening assays |
| 10/26/2005 | EP1588170A2 Articles with protruding conductive coatings |
| 10/26/2005 | EP1588169A2 Articles with dispersed conductive coatings |
| 10/26/2005 | EP1588168A2 Method for separating and detecting at least one analyte in biological matrices |
| 10/26/2005 | EP1588167A2 Sperm specific lysozyme-like proteins |
| 10/26/2005 | EP1588165A2 Vitamin d assay |
| 10/26/2005 | EP1588164A1 Performance improvement for hematology analysis |
| 10/26/2005 | EP1588163A2 Kinases and gpcrs involved in apoptosis |
| 10/26/2005 | EP1588162A2 Hsc70 directed diagnostics and therapeutics for multidrug resistant neoplastic disease |
| 10/26/2005 | EP1588161A1 System and method for measuring coagulation time without thermostatic control |
| 10/26/2005 | EP1588160A2 Method and apparatus for following cells |
| 10/26/2005 | EP1588159A2 Method and system for disease detection using marker combinations |
| 10/26/2005 | EP1588158A1 Device for measuring the quality and/or degradation of a fluid, particularly a food oil |
| 10/26/2005 | EP1588153A1 A cantilever sensor using both the longitudinal and the transversal piezoresistive coefficients |
| 10/26/2005 | EP1588145A2 Methods, mixtures, kits and compositions pertaining to analyte determination |
| 10/26/2005 | EP1588144A2 Glycopeptide identification and analysis |
| 10/26/2005 | EP1588142A2 Methods for diagnosing rcc and other solid tumors |
| 10/26/2005 | EP1588140A2 Cancer-associated nucleic acids and polypeptides |
| 10/26/2005 | EP1588139A2 Rhesus monkey, dog and ferret melanin-concentrating hormone type 2 receptor |
| 10/26/2005 | EP1587955A2 Markers for differential diagnosis and methods of use thereof |
| 10/26/2005 | EP1587951A2 Substrate detection assay |
| 10/26/2005 | EP1587950A2 Cationic anti-microbial peptides and methods of use thereof |
| 10/26/2005 | EP1587917A1 Method for determining the influence of a test substance on the heart activity of a vertebrate |
| 10/26/2005 | EP1587916A2 Cell cycle progression proteins |
| 10/26/2005 | EP1587912A2 Methods of identifying and designing cell surface receptor inhibitors |
| 10/26/2005 | EP1587911A2 Tkts as modifiers of the beta-catenin pathway and methods of use |
| 10/26/2005 | EP1587907A2 Kunitz domain library |
| 10/26/2005 | EP1587843A2 Combinatorial libraries of monomer domains |
| 10/26/2005 | EP1587840A2 Method to form a protein microarray system |
| 10/26/2005 | EP1587839A2 Light induced immobilisation |
| 10/26/2005 | EP1587836A2 Cancerous disease modifying antibodies |
| 10/26/2005 | EP1587835A2 Antibodies specific for plasmacytoid dendritic cells |
| 10/26/2005 | EP1587821A2 Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| 10/26/2005 | EP1587820A2 Isoform specific interactions of apolipoprotein e to an intermediate conformation of alzheimer a beta peptide |
| 10/26/2005 | EP1587819A2 Isolation and purification procedure of vasopeptidase peptide inhibitors |
| 10/26/2005 | EP1587624A1 Sample vessel for analyses |
| 10/26/2005 | EP1587606A1 Generation of efficacy, toxicity and disease signatures and methods of use thereof |
| 10/26/2005 | EP1587542A1 Use of anti-cd100 antibodies |
| 10/26/2005 | EP1587541A2 Compositions and methods of tolerizing a primate to an antigen |
| 10/26/2005 | EP1587532A2 Survivin-derived peptides and use thereof |
| 10/26/2005 | EP1587476A2 Novel compositions and methods in cancer |
| 10/26/2005 | EP1587409A2 Diagnosis and monitoring of inflammation, ischemia and appendicitis |
| 10/26/2005 | EP1587408A2 Glycan markers for diagnosing and monitoring disease |
| 10/26/2005 | EP1587406A2 Quantification of carnitine levels in dialysis patients |
| 10/26/2005 | EP1587405A2 Novel compositions and methods for cancer |
| 10/26/2005 | EP1587365A1 A model of bone disease amenable to high-throughput screening |
| 10/26/2005 | EP1587363A2 Protein production in transgenic avians using lentiviral system |
| 10/26/2005 | EP1576126A3 Systems for capture and analysis of biological particles and methods using the systems |
| 10/26/2005 | EP1517996A4 Test strip and method for determining concentration of creatinine in a body fluid |
| 10/26/2005 | EP1467815B1 Reaction vessel for carrying out array processes |
| 10/26/2005 | EP1463744A4 Devices and methods for isolating and detecting specific substances in complex matrices |
| 10/26/2005 | EP1451580A4 Method of using physiological markers to estimate cardiovascular risk |
| 10/26/2005 | EP1451357A4 Biocatalytic solgel microarrays |
| 10/26/2005 | EP1410019B1 Cardiovascular safety assay |
| 10/26/2005 | EP1390541B1 Method for detecting gram-positive bacteria |
| 10/26/2005 | EP1366195B1 Method for the detection of nucleic acid molecules |
| 10/26/2005 | EP1352247B1 Assay methods for identifying compounds which may protect stratified squamous epithelium against damage by noxious substances |
| 10/26/2005 | EP1352083B1 Compositions and methods for detecting target microorganisms in a sample |
| 10/26/2005 | EP1328236A4 Methods of decreasing or preventing pain using spicamycin derivatives |
| 10/26/2005 | EP1312060B1 Device, method and use of an odor detection unit for examining and/or recording |
| 10/26/2005 | EP1230396B1 Immunological detection of rna:dna hybrids on microarrays |
| 10/26/2005 | EP1179177B1 Polysaccharide structure and sequence determination |
| 10/26/2005 | EP1175614B1 Arrangement for improved water-oil ratio measurements |
| 10/26/2005 | EP1175511B1 Method and kitset for sampling and storage of biological samples |
| 10/26/2005 | EP1167518B1 Method for selectively separating blood cells by using lectin |
| 10/26/2005 | EP1109559B1 Inhibition of pathogenic processes related to tissue trauma |
| 10/26/2005 | EP1102988B1 Method of determining the immune response activity of blood and test kit therefor |